Skip to main content

Table 5 Uni- and multi-variable analysis for predictors of disease specific survival of 49 patients with resection

From: Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status

Factors

Univariate analysis

Multivariate analysis

No. of patients

5-year survival rate (%)

Median survival time (month)

p value

Hazard ratio

(95% CI)

p value

Preoperative CA19–9

  < 25 U/mL

14

59.1

–

0.355

  

 25 U/mL ≦

35

38.6

49.4

   

Preoperative CEA

  < 8.5 ng/mL

42

51.6

–

< 0.001

10.516 (2.213–49.971)

0.003

 8.5 ng/mL ≦

7

0

21.2

   

Neoadjuvant therapy

 not done

22

61.1

–

0.561

  

 done

27

39.2

52.4

   

Adjuvant therapy

 not done

16

53.0

–

0.897

  

 done

33

45.7

57.0

   

Combined vascular resection and reconstruction

 not done

29

31.2

52.4

0.981

  

 done

20

54.0

–

   

Histological differentiation

 G1/G2

45

46.7

57.0

0.001

7.452 (0.904–61.403)

0.062

 G3

3

0

19.1

   

pT factor

 ≦pT3

37

56.1

–

0.001

7.452 (2.348–23.713)

0.001

 pT4≦

12

13.3

31.3

   

Lymph node metastasis

 Negative

26

41.3

57.0

0.389

  

 Positive

23

52.7

–

   

Intrahepatic metastasis

 Absent

46

45.4

57.0

0.033

0.693 (0.053–9.005)

0.779

 Present

3

0

–

   

Curative resection

 R0

32

61.5

–

0.037

2.283 (0.739–7.058)

0.152

 R1,2

17

15.1

35.7

   
  1. CEA carcinoembryonic antigen, CA19–9 carbohydrate antigen 19–9, R0 complete resection,R1 microscopic residual tumor resection, R2 macroscopic residual tumor resection or distant metastasis (intrahepatic metastasis)